Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- University Hospitals Cleveland Medical Center
- Study ID
- NCT05345457
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- PROM (Pregnancy)
- PROM, Preterm (Pregnancy)
- Pregnancy Preterm
- Pregnancy Prom
- Premat Rupture Membranes Preterm Unspec to Length of Time Between Rupture/Labor
- Premature Birth
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Azithromycin Pill — DRUGAzithromycin will be dosed as single 500 mg dose (2-250mg oral tablets) administered immediately following randomization, yet prior to discharge to home, followed with 1-250mg oral tablet daily for 4 additional days (for a total of 5 days).
- Amoxicillin Pill — DRUGAmoxicillin will be dosed as a single-500mg oral tablet three times daily for 7 days with first dose also being given prior to discharge home.
Study Details
A randomized, controlled, non-placebo trial to primarily assess the effect of oral, outpatient antibiotics (i.e., azithromycin and amoxicillin) on latency (i.e., proportion of patients that deliver within 28 days from membrane rupture) following previable, prelabor rupture of membranes between 18 0/7 and 22 6/7 weeks gestational age.
Key Dates
- Start date
- Jan 13, 2023
- Status verified
- Apr 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 88 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: AntibioticsPatients randomized into the treatment (i.e., antibiotics) arm of the study will be treated with a seven-day course of oral azithromycin and amoxicillin. Azithromycin will be dosed as single 500 mg dose (2-250mg oral tablets) administered immediately following randomization, yet prior to discharge to home, followed with 1-250mg oral tablet daily for 4 additional days (for a total of 5 days). Amoxicillin will be dosed as a single-500mg oral tablet three times daily for 7 days with first dose also being given prior to discharge home.
- No Intervention: No antibioticsPatients randomized into the control (i.e., no antibiotics arm) will be managed according to standard of care practices for previable PPROM desiring of expectant management.
Primary Outcome Measure
Delivery within 28 days [ Time Frame: 28 days from date of rupture ]
Central Contacts
- Felicia LeMoine, MD(216) 983-6606
- David Hackney, MD(216) 844-3787
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44111 | |
| MetroHealth | Cleveland | Ohio | 44109 | |
| University Hospitals | Cleveland | Ohio | 44106 |
Find similar trials in Cleveland, OH
Related Studies
- The Periviable GOALS Decision Support ToolRecruiting · Indiana University · San Diego, California
- Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum DatasetRecruiting · The University of Texas Health Science Center, Houston · Birmingham, Alabama
- Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm InfantsRecruiting · Thrive Neuromedical, LLC · Atlanta, Georgia
- PPROM Registry (Preterm Premature Rupture of Membranes)Recruiting · American Alliance for pProm Support · Denver, Colorado